Structures by: Liu J. C.
Total: 70
C6H18N3,3(Cl)
C6H18N3,3(Cl)
CrystEngComm (2020)
a=8.0160(5)Å b=8.0160(5)Å c=15.1863(12)Å
α=90° β=90° γ=120°
3(Cl),C6H18N3
3(Cl),C6H18N3
CrystEngComm (2020)
a=10.9842(3)Å b=7.9342(2)Å c=25.1271(7)Å
α=90° β=91.717(2)° γ=90°
C74H56Co3N12O18
C74H56Co3N12O18
New J. Chem. (2016) 40, 6 5010
a=9.6519(5)Å b=14.0468(14)Å c=14.7341(14)Å
α=117.367(10)° β=99.409(6)° γ=94.091(6)°
C92H72Co3N12O20
C92H72Co3N12O20
New J. Chem. (2016) 40, 6 5010
a=11.7113(6)Å b=10.4600(5)Å c=33.1080(16)Å
α=90.00° β=94.1870(10)° γ=90.00°
C37H26CoN4O9
C37H26CoN4O9
New J. Chem. (2016) 40, 6 5010
a=16.136(2)Å b=9.3687(13)Å c=21.052(3)Å
α=90.00° β=94.838(2)° γ=90.00°
C61H60N16O14Zn2
C61H60N16O14Zn2
CrystEngComm (2019) 21, 15 2559
a=8.2598(6)Å b=13.9770(11)Å c=30.125(2)Å
α=90.00° β=90.00° γ=90.00°
C34H31N7O7Zn
C34H31N7O7Zn
CrystEngComm (2019) 21, 15 2559
a=10.772(5)Å b=30.453(14)Å c=10.404(5)Å
α=90.00° β=102.632(7)° γ=90.00°
C44.45H28.90Br3Cl0.90N4Sb
C44.45H28.90Br3Cl0.90N4Sb
Chemical Communications (Cambridge, United Kingdom) (2003) 15 1908-1909
a=17.781(1)Å b=7.6026(3)Å c=15.0019(8)Å
α=90° β=90° γ=90°
C46H31Br2Cl4N4Sb
C46H31Br2Cl4N4Sb
Chemical Communications (Cambridge, United Kingdom) (2003) 15 1908-1909
a=13.394(2)Å b=9.9906(7)Å c=16.672(2)Å
α=90° β=95.107(2)° γ=90°
C45.50H29.50Br5Cl4.50N4Sb
C45.50H29.50Br5Cl4.50N4Sb
Chemical Communications (Cambridge, United Kingdom) (2003) 15 1908-1909
a=22.5586(3)Å b=17.5209(3)Å c=22.9152(4)Å
α=90° β=90.0793(6)° γ=90°
C10H14Cu2Mo2N2O11
C10H14Cu2Mo2N2O11
Chemical Communications (2002) 2 152
a=7.4488(2)Å b=9.2576(1)Å c=13.9332(4)Å
α=71.992(2)° β=89.745(2)° γ=73.640(2)°
C30H25Co2N2O10
C30H25Co2N2O10
New J. Chem. (2016) 40, 6 5010
a=21.087(4)Å b=21.087(4)Å c=12.382(3)Å
α=90.00° β=90.00° γ=90.00°
C38H54DyO12P2,3(Cl),2(H2O)
C38H54DyO12P2,3(Cl),2(H2O)
Dalton transactions (Cambridge, England : 2003) (2019) 48, 8 2735-2740
a=30.906(2)Å b=20.3398(15)Å c=7.5421(6)Å
α=90° β=90° γ=90°
C38H54GdO12P2,3(Cl)[solvent]
C38H54GdO12P2,3(Cl)[solvent]
Dalton transactions (Cambridge, England : 2003) (2019) 48, 8 2735-2740
a=30.875(3)Å b=20.3031(17)Å c=7.5804(6)Å
α=90° β=90° γ=90°
C38H54ErO12P2,3(Cl),(H2O)[solvent]
C38H54ErO12P2,3(Cl),(H2O)[solvent]
Dalton transactions (Cambridge, England : 2003) (2019) 48, 8 2735-2740
a=30.722(2)Å b=20.3442(14)Å c=7.5758(5)Å
α=90° β=90° γ=90°
C11H9CuO6P
C11H9CuO6P
Dalton transactions (Cambridge, England : 2003) (2019) 48, 19 6539-6545
a=5.1011(6)Å b=6.0470(7)Å c=18.034(2)Å
α=84.761(8)° β=87.211(8)° γ=74.855(7)°
2(C11H9CuO6P),2(HO0.50)
2(C11H9CuO6P),2(HO0.50)
Dalton transactions (Cambridge, England : 2003) (2019) 48, 19 6539-6545
a=42.026(17)Å b=7.671(3)Å c=7.729(3)Å
α=90° β=93.147(7)° γ=90°
C18H36GdMo6N3O33
C18H36GdMo6N3O33
Journal of the Chemical Society, Dalton Transactions (2001) 21 3202
a=16.344(4)Å b=16.344(4)Å c=26.728(7)Å
α=90.00° β=90.00° γ=120.00°
C8H16Cu2N24O6
C8H16Cu2N24O6
Journal of the Chemical Society, Dalton Transactions (1999) 14 2337
a=7.0069(11)Å b=8.533(2)Å c=11.013(2)Å
α=70.95(2)° β=84.824(13)° γ=74.253(15)°
C2H4Cu1.50N13
C2H4Cu1.50N13
Journal of the Chemical Society, Dalton Transactions (1999) 14 2337
a=8.4444(15)Å b=11.1376(13)Å c=9.994(2)Å
α=90.00° β=98.48(2)° γ=90.00°
C44.45H28.90Br3Cl0.90N4Sb
C44.45H28.90Br3Cl0.90N4Sb
Chemical Communications (Cambridge, United Kingdom) (2003) 15 1908-1909
a=17.781(1)Å b=7.6026(3)Å c=15.0019(8)Å
α=90° β=90° γ=90°
C46H31Br2Cl4N4Sb
C46H31Br2Cl4N4Sb
Chemical Communications (Cambridge, United Kingdom) (2003) 15 1908-1909
a=13.394(2)Å b=9.9906(7)Å c=16.672(2)Å
α=90° β=95.107(2)° γ=90°
C45.50H29.50Br5Cl4.50N4Sb
C45.50H29.50Br5Cl4.50N4Sb
Chemical Communications (Cambridge, United Kingdom) (2003) 15 1908-1909
a=22.5586(3)Å b=17.5209(3)Å c=22.9152(4)Å
α=90° β=90.0793(6)° γ=90°
C20H16Cl4Cu2N12
C20H16Cl4Cu2N12
CrystEngComm (2013) 15, 32 6359
a=14.870(6)Å b=19.709(8)Å c=8.759(3)Å
α=90.00° β=106.423(4)° γ=90.00°
C10H13Cl3CuN6O10
C10H13Cl3CuN6O10
CrystEngComm (2013) 15, 32 6359
a=10.8122(10)Å b=11.1482(11)Å c=31.445(3)Å
α=90.00° β=90.00° γ=90.00°
C10H15ClCuN8O9
C10H15ClCuN8O9
CrystEngComm (2013) 15, 32 6359
a=32.804(3)Å b=6.6637(6)Å c=21.391(2)Å
α=90.00° β=128.802(5)° γ=90.00°
C20H17Cl3Cu2N12O5
C20H17Cl3Cu2N12O5
CrystEngComm (2013) 15, 32 6359
a=14.641(7)Å b=14.569(7)Å c=12.478(6)Å
α=90.00° β=94.490(4)° γ=90.00°
C20H21Cl2Cu2N13O6
C20H21Cl2Cu2N13O6
CrystEngComm (2013) 15, 32 6359
a=11.2535(6)Å b=11.9210(10)Å c=12.0912(9)Å
α=92.170(7)° β=115.524(6)° γ=107.005(6)°
4-{2-[(Pyridin-3-yl)methyl]-2<i>H</i>-tetrazol-5-yl}pyridine
C12H10N6
Acta Crystallographica Section C (2021) 77, 1 29-39
a=13.7529(8)Å b=6.6451(4)Å c=12.2086(9)Å
α=90.00° β=93.634(6)° γ=90.00°
Bis(μ-4-{2-[(pyridin-3-yl)methyl]-2<i>H</i>-tetrazol-5-yl}pyridine)bis[dichloridozinc(II)] dichloromethane disolvate
C24H20Cl4N12Zn2,2(CH2Cl2)
Acta Crystallographica Section C (2021) 77, 1 29-39
a=30.503(4)Å b=8.8791(11)Å c=15.4063(17)Å
α=90° β=116.856(5)° γ=90°
Bis(μ-4-{2-[(pyridin-3-yl)methyl]-2<i>H</i>-tetrazol-5-yl}pyridine)bis[diiodidozinc(II)] dichloromethane disolvate
C24H20I4N12Zn2,2(CH2Cl2)
Acta Crystallographica Section C (2021) 77, 1 29-39
a=30.312(10)Å b=9.461(3)Å c=15.434(5)Å
α=90° β=114.625(4)° γ=90°
Bis(μ-4-{2-[(pyridin-3-yl)methyl]-2<i>H</i>-tetrazol-5-yl}pyridine)bis[dichloridozinc(II)] chloroform monosolvate
C24H20Cl4N12Zn2,CHCl3
Acta Crystallographica Section C (2021) 77, 1 29-39
a=13.414(9)Å b=18.504(12)Å c=14.674(10)Å
α=90° β=105.834(9)° γ=90°
<i>catena</i>-Poly[[[diiodidozinc(II)]-μ-4-{2-[(pyridin-3-yl)methyl]-2<i>H</i>-tetrazol-5-yl}pyridine] chloroform monosolvate]
C12H10I2N6Zn,CHCl3
Acta Crystallographica Section C (2021) 77, 1 29-39
a=9.804(13)Å b=11.350(14)Å c=11.350(14)Å
α=69.430(14)° β=65.912(18)° γ=65.912(18)°
Poly[diaqua(μ~4~-1,4-bis{[1-(pyridin-3-ylmethyl)-1<i>H</i>-benz[<i>d</i>]imidazol-2-yl]methoxy}benzene)bis(μ~2~-isophthalato)dicadmium(II)]
C25H20CdN3O6
Acta Crystallographica Section C (2016) 72, 10 724-729
a=9.9608(8)Å b=10.5480(10)Å c=11.1137(13)Å
α=108.408(10)° β=99.712(8)° γ=96.218(7)°
Poly[diaqua(μ~4~-1,4-bis{[1-(pyridin-3-ylmethyl)-1<i>H</i>-benz[<i>d</i>]imidazol-2-yl]methoxy}benzene)bis(μ~2~-isophthalato)dicobalt(II)]
C25H20CoN3O6
Acta Crystallographica Section C (2016) 72, 10 724-729
a=9.995(2)Å b=10.294(2)Å c=10.796(2)Å
α=108.73(3)° β=99.81(3)° γ=94.99(3)°
<i>catena</i>-Poly[[[aqua{4-[4-(1<i>H</i>-imidazol-1-yl-κ<i>N</i>^3^)phenyl]pyridine}cadmium(II)]-μ-5-hydroxybenzene-1,3-dicarboxylato-κ^3^<i>O</i>^1^,<i>O</i>^1^:<i>O</i>^3^] monohydrate]
C36H28CdN6O6,H2O
Acta Crystallographica Section C (2016) 72, 5 389-392
a=9.9863(4)Å b=10.3722(5)Å c=15.7502(7)Å
α=91.755(4)° β=99.029(5)° γ=95.042(3)°
<i>catena</i>-Poly[[[tetraaquazinc(II)]-μ-1,4-bis[4-(1<i>H</i>-imidazol-1-yl)benzoyl]piperazine] dinitrate monohydrate]
C24H30N6O6Zn2,2(NO3),2(H2O)
Acta Crystallographica Section E (2015) 71, 5 m120-m121
a=22.051(4)Å b=7.8861(16)Å c=17.837(4)Å
α=90.00° β=102.65(3)° γ=90.00°
Bis[1,2-bis(diphenylphosphino)ethene)]nickel(II) diperchlorate
C52H44NiP42,2ClO41
Acta Crystallographica Section E (2002) 58, 5 m237-m238
a=10.8450(10)Å b=16.1980(10)Å c=13.1980(10)Å
α=90.00° β=95.260(10)° γ=90.00°
Anthrapinacol
C28H22O2
Acta Crystallographica Section E (2005) 61, 7 o2035-o2037
a=14.789(6)Å b=12.853(5)Å c=10.688(4)Å
α=90.00° β=92.549(6)° γ=90.00°
3-(4-Chlorophenyl)-5-methyl-2-propylamino-8,9,10,11-tetrahydro- 2-benzothieno[2'3';2,3]pyrido[4,5-d]pyrimidin-4(3H)-one
C23H23ClN4OS
Acta Crystallographica Section E (2005) 61, 10 o3187-o3189
a=11.8884(6)Å b=13.3784(7)Å c=15.7892(8)Å
α=114.0540(10)° β=98.9260(10)° γ=101.3350(10)°
8-Butylamino-1,2,5-trimethyl-7-p-tolyl-3-thia-4,7,9- triazacyclopenta[a]naphthalen-6(7H)-one
C23H26N4OS
Acta Crystallographica Section E (2005) 61, 11 o3642-o3644
a=21.5659(19)Å b=9.0711(8)Å c=22.646(2)Å
α=90.00° β=109.746(2)° γ=90.00°
C24H17Cl2N3O2S
C24H17Cl2N3O2S
Acta Crystallographica Section E (2005) 61, 10 o3259-o3260
a=11.1861(17)Å b=10.3346(16)Å c=19.517(3)Å
α=90.00° β=101.377(3)° γ=90.00°
2-(4-Chloro-3-methylphenoxy)-3-(4-chlorophenyl)-5-methyl- 8,9,10,11-tetrahydro-1-benzothieno[2',3':2,3]pyrido[4,5-d]pyrimidin-4(3H)-one
C27H21Cl2N3O2S,CH2Cl2
Acta Crystallographica Section E (2005) 61, 11 o3686-o3687
a=18.564(3)Å b=10.6834(17)Å c=28.510(4)Å
α=90.00° β=90.00° γ=90.00°
3-(4-Chlorophenyl)-2-(2,4-dichlorophenoxy)-5-methyl-8,9,10,11-tetrahydro- 2-benzothieno[2',3':2,3]pyrido[4,5-<i>d</i>]pyrimidin-4(3<i>H</i>)-one dichloromethane solvate
C26H18Cl3N3O2S,CH2Cl2
Acta Crystallographica Section E (2007) 63, 12 o4571-o4571
a=18.295(6)Å b=10.851(4)Å c=28.097(9)Å
α=90.00° β=90.00° γ=90.00°
<i>catena</i>-Poly[[silver(I)-μ-{2-[2-(pyridin-4-yl)-1<i>H</i>-benzimidazol-1-ylmethyl]phenol-κ^2^<i>N</i>^2^:<i>N</i>^3^}] perchlorate monohydrate]
C19H15AgN3O,ClO4,H2O
Acta Crystallographica Section C (2013) 69, 4 356-359
a=9.739(3)Å b=21.260(7)Å c=9.952(3)Å
α=90.00° β=103.851(3)° γ=90.00°
Bis[methylenebis(diphenylphosphine)-P,P']nickel(II) diperchlorate
C50H44NiP42,2ClO41
Acta Crystallographica Section C (2000) 56, 7 e286-e287
a=11.226(2)Å b=17.836(2)Å c=12.932(2)Å
α=90° β=111.320(10)° γ=90°
Bis{2-[bis(3,5-dimethyl-1<i>H</i>-pyrazol-1-yl-κ<i>N</i>^2^)methyl]pyridine- κ<i>N</i>}copper(II) dinitrate
C32H38CuN102,2(NO3)
Acta Crystallographica Section E (2011) 67, 12 m1691
a=24.819(6)Å b=10.918(3)Å c=17.592(4)Å
α=90.00° β=132.348(2)° γ=90.00°
Dichlorido{<i>N</i>-[1-(pyrazin-2-yl)ethylidene-κ<i>N</i>^1^]ethane-1,2- diamine-κ^2^<i>N</i>,<i>N</i>}zinc
C8H12Cl2N4Zn
Acta Crystallographica Section E (2011) 67, 11 m1555
a=7.106(5)Å b=8.976(6)Å c=10.225(6)Å
α=69.566(5)° β=73.434(5)° γ=83.056(5)°
Dichloridobis[2-(1-hydrazinylideneethyl)pyrazine-κ<i>N</i>^1^]zinc
C12H16Cl2N8Zn
Acta Crystallographica Section E (2012) 68, 5 m710
a=8.4289(8)Å b=15.1128(14)Å c=13.4196(13)Å
α=90.00° β=104.0770(10)° γ=90.00°
Aqua[1-(pyrazin-2-yl)ethanone oximato-κ^2^<i>N</i>,<i>N</i>][1-(pyrazin-2-yl)ethanone oxime-κ^2^<i>N</i>,<i>N</i>'](thiocyanato-κ<i>N</i>)nickel(II)
C13H15N7NiO3S
Acta Crystallographica Section E (2012) 68, 7 m883
a=11.917(8)Å b=11.899(8)Å c=12.354(8)Å
α=90.00° β=108.220(5)° γ=90.00°
Dimethyl 2,2'-[2,2'-bi(1<i>H</i>-1,3-benzimidazole)-1,1'-diyl]diacetate
C20H18N4O4
Acta Crystallographica Section E (2012) 68, 8 o2512
a=6.904(4)Å b=8.494(5)Å c=8.643(5)Å
α=67.191(5)° β=70.360(5)° γ=87.172(5)°
1,3-Dimethyl-1<i>H</i>-1,2,3-benzotriazol-3-ium tetrachloridoferrate(III)
C8H10N3,Cl4Fe
Acta Crystallographica Section E (2013) 69, 3 m148
a=10.2920(5)Å b=12.5518(6)Å c=22.5857(9)Å
α=90.00° β=90.00° γ=90.00°
Bis[2-(1<i>H</i>-benzotriazol-1-yl)-1<i>H</i>-benzimidazol-1-ido]diethanolcadmium
C30H28Cd1N10O2
Acta Crystallographica Section E (2013) 69, 3 m134
a=8.7544(4)Å b=8.0112(2)Å c=20.9382(9)Å
α=90.00° β=101.352(5)° γ=90.00°
(3,3-{(1<i>E</i>,1'<i>E</i>)-1,1'-[Ethane-1,2-diylbis(azan-1-yl-1-ylidene-κ<i>N</i>)]bis(ethan-1-yl-1-ylidene)}dipyrazine 1-oxide-κ<i>N</i>^4^)bis(nitrato-κ<i>O</i>)nickel(II) monohydrate
C14H16N8NiO8,H2O
Acta Crystallographica Section E (2013) 69, 5 m263-m264
a=16.993(5)Å b=16.218(5)Å c=7.754(2)Å
α=90.00° β=113.427(3)° γ=90.00°
2-{[2-(Pyridin-4-yl)-1<i>H</i>-benzimidazol-1-yl]methyl}phenol
C19H15N3O
Acta Crystallographica Section E (2013) 69, 5 o700
a=16.1886(7)Å b=8.4863(4)Å c=21.4316(10)Å
α=90.00° β=93.756(4)° γ=90.00°
C31H31IrN3O5P
C31H31IrN3O5P
ACS omega (2019) 4, 15 16543-16550
a=12.232(2)Å b=15.846(3)Å c=15.553(3)Å
α=90° β=105.279(3)° γ=90°
C48H32Co3N2O17
C48H32Co3N2O17
Crystal Growth & Design (2015) 15, 12 5781
a=10.9329(6)Å b=28.9340(13)Å c=15.0328(7)Å
α=90.00° β=90.370(5)° γ=90.00°
C68H50Co3N6O18
C68H50Co3N6O18
Crystal Growth & Design (2015) 15, 12 5781
a=33.240(3)Å b=11.4583(6)Å c=16.7276(9)Å
α=90.00° β=102.785(7)° γ=90.00°
C74H52Co3N12O16
C74H52Co3N12O16
Crystal Growth & Design (2015) 15, 12 5781
a=11.7607(17)Å b=11.8567(17)Å c=13.6483(16)Å
α=99.178(11)° β=104.016(11)° γ=114.946(14)°
C37H28Co2N4O10
C37H28Co2N4O10
Crystal Growth & Design (2015) 15, 12 5781
a=8.8481(9)Å b=12.215(3)Å c=15.904(2)Å
α=85.741(15)° β=75.085(10)° γ=76.445(13)°
C92H60Co3N12O14
C92H60Co3N12O14
Crystal Growth & Design (2015) 15, 12 5781
a=11.852(3)Å b=12.333(7)Å c=14.889(7)Å
α=92.06(7)° β=109.36(4)° γ=106.58(4)°
C16H16Cd2N0O14
C16H16Cd2N0O14
Crystal Growth & Design (2015) 15, 5 2419
a=18.516(3)Å b=7.9896(11)Å c=16.502(2)Å
α=90.00° β=118.946(2)° γ=90.00°
C26H20N2O12Zn2
C26H20N2O12Zn2
Crystal Growth & Design (2015) 15, 5 2419
a=7.6683(5)Å b=41.941(3)Å c=7.8187(6)Å
α=90.00° β=104.516(8)° γ=90.00°
C240H232N48Ni9O90
C240H232N48Ni9O90
Crystal Growth & Design (2015) 15, 5 2419
a=8.7712(5)Å b=22.9092(17)Å c=32.3091(14)Å
α=76.589(5)° β=89.490(4)° γ=82.229(6)°
C124H104N12Ni7O52
C124H104N12Ni7O52
Crystal Growth & Design (2015) 15, 5 2419
a=10.0879(7)Å b=11.3386(8)Å c=28.2595(16)Å
α=89.390(5)° β=81.837(5)° γ=87.109(6)°
C32H30.8Cu5O26.4
C32H30.8Cu5O26.4
Crystal Growth & Design (2015) 15, 5 2419
a=10.7643(4)Å b=11.1903(5)Å c=11.8805(6)Å
α=101.006(4)° β=110.549(4)° γ=99.779(4)°
C31H29N3Ni1.5O14
C31H29N3Ni1.5O14
Crystal Growth & Design (2015) 15, 5 2419
a=37.359(2)Å b=7.7625(2)Å c=22.3426(7)Å
α=90.00° β=91.094(4)° γ=90.00°
C11H9CuO6P
C11H9CuO6P
Dalton transactions (Cambridge, England : 2003) (2019) 48, 19 6539-6545
a=37.542(3)Å b=7.6994(7)Å c=7.7667(7)Å
α=90° β=90.3320(10)° γ=90°
C27H17F4IrN3O3P
C27H17F4IrN3O3P
ACS omega (2019) 4, 15 16543-16550
a=34.92(3)Å b=10.096(8)Å c=16.247(13)Å
α=90° β=104.980(14)° γ=90°
C36H32Cd2N4O14
C36H32Cd2N4O14
Crystal Growth & Design (2015) 15, 5 2419
a=21.1595(6)Å b=10.0443(2)Å c=16.9449(4)Å
α=90.00° β=100.237(2)° γ=90.00°